Combination therapy for treatment of multiple sclerosis

This publication has 7 references indexed in Scilit:

• Synergistic immunomodulatory effects of interferon‐β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing‐remitting multiple sclerosis
  Annals of Neurology, 1998
• All-trans Retinoic Acid Potentiates the Ability of Interferon Beta-1b to Augment Suppressor Cell Function in Multiple Sclerosis
  Archives of Neurology, 1998
• Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
  The Lancet, 1997
• Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
  Annals of Neurology, 1996
• Additive effects of copolymer-1 and interferon β-1b on the immune response to myelin basic protein
  Journal of Neuroimmunology, 1995
• The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosis
  Annals of Neurology, 1995
• Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis
  Annals of Neurology, 1995